Powered by: Motilal Oswal
2025-09-26 05:27:28 pm | Source: Religare Broking Ltd
Quote on the Pharma Sector 26th September 2025 by Ajit Mishra, SVP, Research, Religare Broking
Quote on the Pharma Sector 26th September 2025 by Ajit Mishra, SVP, Research, Religare Broking

Below the Quote on the Pharma Sector 26th September 2025 by Ajit Mishra, SVP, Research, Religare Broking

 

"The latest US move to slap a 100% tariff on branded and patented pharmaceuticals has shaken up the global pharma sector, especially for Indian drugmakers. While the announcement stirred sharp falls in pharma stocks, the actual impact for now is focused on branded, patent-protected medicines—most Indian exports are generics, which remain exempt. Still, the uncertainty around future policy shifts keeps nerves on edge. For India’s pharma giants, this is a wake-up call to strengthen supply chains and explore US-based manufacturing, even as the sector’s core strength in affordable generics continues to support global healthcare"

 

 

 

Above views are of the author and not of the website kindly read disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here